Can I Use MaxCyte® Electroporation for My Cell Type?

MaxCyte has the industry-leading electroporation technology devised to enable the development of an engineered cell therapy using patient cells. We created a system with fragile cells in mind, using clinical-grade, non-toxic components. Our optimized cell-specific electroporation protocols draw on decades of cell-handling experience.

Because the cells you use always matter, our technology delivers high-efficiency transfection and superior cell viability for any cell.

Cell Types

Immortalized Mammalian Cells

  • 10T½
  • Ba/F3
  • BHK-21
  • C127
  • C2C12
  • CAP/CAP-T
  • CHO
  • COS-7
  • HEK-293
  • Jurkat
  • L6
  • LLC-PK1
  • MDCK
  • NIH/3T3
  • NRK
  • PC12
  • Per.C6
  • RAW264.7
  • RBL
  • Vero

Mammalian Cancer Cell Lines

  • A549
  • B16
  • EL4
  • HCT-116
  • HeLa
  • HT-1080
  • K562
  • LNCaP
  • MCF7
  • MG-63
  • Neuro2a
  • NS0
  • PANC-1
  • Renca
  • SK-N-SH
  • SK-OV-3
  • SNU-1
  • Sp2/0
  • THP-1
  • YB2/0

Hematological Cells

  • B cells
  • Dendritic cells
  • Granulocytes
  • 𝛾𝛿 T cells
  • Hematopoietic Stem Cells (HSCs)
  • Macrophages
  • Megakaryocytes
  • Monocytes
  • NK cells
  • Peripheral Blood Mononuclear Cells (PBMCs)
  • Platelets
  • T cells

Primary Cells

  • Fibroblasts
  • Keratinocytes
  • Myoblasts
  • Neurons

Stem Cells

  • Embryonic Stem Cells
  • Induced Pluripotent Stem Cells (iPSCs)
  • Mesenchymal Stem Cells (MSCs)
  • Neural Stem Cells / Neural Progenitor Cells (NPCs)

Insect Cell Lines

  • S2
  • Sf9
  • Sf21
  • SL3

Don’t see your cells here?

Related Resources

AP-CRISPR-T-Cells@2x
Application Note
CRISPR Electroporation of T Cells Improves Treatment in Patients with Refractory Cancer.
TEI-graphic@2x (1)
Poster
Non-Viral Engineering of Human iPSCs to Manufacture Rejuvenated TCR T Cells for Cancer Immunotherapy.
MaxCyte-Enables-Multiplexed-NK-Cell-Engineering2@2x
Application Note
MaxCyte® Enables Multiplexed NK Cell Engineering.
View All Resources